While not reaching significance, the expression of MUC-2 increased in MH002-treated organoids (Figure 6E), and CLDN-2 expression, a pore-forming claudin described to be upregulated in IBD and contributing to diarrhea [30], decreased (Figure 6D). Here, MUC2 is linked to inflammatory bowel disease.